4.4 Article

Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex

Journal

BIOCHEMISTRY
Volume 47, Issue 28, Pages 7485-7495

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/bi800438k

Keywords

-

Funding

  1. NHLBI NIH HHS [R01 HL 085234] Funding Source: Medline

Ask authors/readers for more resources

The interaction of Cardiac Troponin C (cTnC) and Cardiac Troponin I (cTnI) plays a critical role in transmitting the Call signal to the other myofilament proteins in the activation of cardiac muscle contract ion. As such,. the cTnC-cTnI interface is a logical target for cardiotonic agents such as levosimendan that can modulate the Ca(2+) sensitivity of the myofilaments. Evidence indicates that drug candidates may exert their effects by targeting a site formed by binding of the switch region of cTnI to the regulatory N domain of cTnC (cNTnC). In this study, we utilized two-dimensional (1)H-(15)N HSQC NMR spectroscopy to monitor the binding of levosimendan and its analogues, CMDP, AMDP, CI-930, imazodan, and MPDP, to cNTnC center dot Ca(2+) in complex with two versions of the switch region of cTnI (cTnI(147-163) and cTnI(144-163)). Levosimendan, CMDP, AMDP, and CI-930 were found to bind to both cNTnC center dot Ca(2+)cTnI(147-163) and cNTnC center dot Ca(2+)center dot cTn(144-163) complexes. These compounds contain a methyl group that is absent in MPDP or imazodan. Thus, the methyl group is one of the pharmacophores responsible for the action of these pyridazinone drugs on cTnC. Furthermore, the results showed that the cNTnC center dot Ca(2+)center dot cTnI(144-163) complex presents a higher-affinity binding site for these compounds than the cNTnC center dot Ca(2+) similar to cTnI(147-163) complex. This is consistent with our observation that the affinity of cTnI(144-163) for cNTnC center dot Ca(2+) is similar to 10-fold stronger than that of cTnI(147-163), likely a result of electrostatic forces between the N-terminal RRV extension in cTnI(144-163) and the acidic residues in the C and D helices of cNTnC. These results will help in the delineation of the mode of action of levosimendan on the important functional unit of cardiac troponin that constitutes the regulatory domain of cTnC and the switch region of cTnI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available